Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease

Citation
Sm. Sanz-gonzalez et al., Control of vascular smooth muscle cell growth by cyclin-dependent kinase inhibitory proteins and its implication in cardiovascular disease, FRONT BIOSC, 5, 2000, pp. D619-D628
Citations number
139
Categorie Soggetti
Biochemistry & Biophysics
Journal title
FRONTIERS IN BIOSCIENCE
ISSN journal
10939946 → ACNP
Volume
5
Year of publication
2000
Pages
D619 - D628
Database
ISI
SICI code
1093-9946(20000701)5:<D619:COVSMC>2.0.ZU;2-B
Abstract
While quiescence is a defining characteristic of differentiated vascular sm ooth muscle cells (VSMCs) residing within the medial layer of elastic arter ies in the adult organism, mature VSMCs can undergo phenotypic modulation a nd reenter the cell cycle in response to several physiological and patholog ical stimuli. Abnormal VSMC proliferation is thought to contribute to the p athogenesis of vascular occlusive lesions, including atherosclerosis, vesse l renarrowing after successful angioplasty (restenosis), and graft atherosc lerosis after coronary transplantation. Therefore, elucidating the molecula r mechanisms limiting VSMC growth is currently the subject of active resear ch. This review will focus on the role of cyclin-dependent kinase inhibitor y proteins in the regulation of VSMC proliferation and its implication in i ntimal lesion formation during the pathogenesis of vascular proliferative d iseases.